Literature DB >> 15662550

Characterisation of glucose transporters in the intact coronary artery endothelium in rats: GLUT-2 upregulated by long-term hyperglycaemia.

N Gaudreault1, D R L Scriven, E D W Moore.   

Abstract

AIMS/HYPOTHESIS: We have examined the effects of streptozotocin-induced type 1 diabetes on the expression and subcellular distribution of the classic sugar transporters (GLUT-1 to 5 and sodium-dependent glucose transporter-1 [SGLT-1]) in the endothelial cells of an en face preparation of septal coronary artery from Wistar rats.
METHODS: The presence of the GLUT isoforms and SGLT-1 in the endothelial cell layer was determined by immunohistochemistry using wide-field fluorescence microscopy coupled to deconvolution, and was quantified by digital image analysis.
RESULTS: We found that all of the transporters were expressed within these cells and that all except SGLT-1 were preferentially located on the abluminal side. The heaviest labelling was adjacent to the cell-to-cell junctions where the luminal and abluminal membranes are in close proximity, which may reflect a spatial organisation specialised for vectorial glucose transport across the thinnest part of the cytoplasm. Long-term hyperglycaemia, induced by streptozotocin, significantly downregulated GLUT-1, 3, 4 and 5 and dramatically upregulated GLUT-2, leaving SGLT-1 unchanged. CONCLUSIONS/
INTERPRETATION: We conclude that the high susceptibility of endothelial cells to glucose toxicity may be the result of the subcellular organisation of their GLUTs and the increased expression of GLUT-2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15662550     DOI: 10.1007/s00125-004-1583-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  67 in total

Review 1.  Signaling mechanisms underlying the vascular myogenic response.

Authors:  M J Davis; M A Hill
Journal:  Physiol Rev       Date:  1999-04       Impact factor: 37.312

2.  Immunolocalization of glucose transporter GLUT4 within human skeletal muscle.

Authors:  J E Friedman; R W Dudek; D S Whitehead; D L Downes; W R Frisell; J F Caro; G L Dohm
Journal:  Diabetes       Date:  1991-01       Impact factor: 9.461

3.  Short-term insulin treatment prevents the diabetogenic action of streptozotocin in rats.

Authors:  J Thulesen; C Orskov; J J Holst; S S Poulsen
Journal:  Endocrinology       Date:  1997-01       Impact factor: 4.736

4.  Forebrain endothelium expresses GLUT4, the insulin-responsive glucose transporter.

Authors:  A L McCall; A M van Bueren; L Huang; A Stenbit; E Celnik; M J Charron
Journal:  Brain Res       Date:  1997-01-09       Impact factor: 3.252

5.  Transient and steady-state effects of shear stress on endothelial cell adherens junctions.

Authors:  S Noria; D B Cowan; A I Gotlieb; B L Langille
Journal:  Circ Res       Date:  1999-09-17       Impact factor: 17.367

6.  Functional NMDA receptor subtype 2B is expressed in astrocytes after ischemia in vivo and anoxia in vitro.

Authors:  Claudia Krebs; Herman B Fernandes; Claire Sheldon; Lynn A Raymond; Kenneth G Baimbridge
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

7.  GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice.

Authors:  Z Wang; H Gleichmann
Journal:  Diabetes       Date:  1998-01       Impact factor: 9.461

8.  Diabetes increases facilitative glucose uptake and GLUT2 expression at the rat proximal tubule brush border membrane.

Authors:  Joanne Marks; Nicolas J C Carvou; Edward S Debnam; Surjit K Srai; Robert J Unwin
Journal:  J Physiol       Date:  2003-09-08       Impact factor: 5.182

9.  Overexpression of glucose transporter protein 5 in sciatic nerve of streptozotocin-induced diabetic rats.

Authors:  T Asada; S Takakura; T Ogawa; M Iwai; M Kobayashi
Journal:  Neurosci Lett       Date:  1998-08-14       Impact factor: 3.046

10.  Immunoelectron characterisation of the inter-endothelial junctions of human term placenta.

Authors:  L Leach; P Clark; M G Lampugnani; A G Arroyo; E Dejana; J A Firth
Journal:  J Cell Sci       Date:  1993-04       Impact factor: 5.285

View more
  10 in total

Review 1.  Endothelial dysfunction in diabetes: multiple targets for treatment.

Authors:  Hong Ding; Chris R Triggle
Journal:  Pflugers Arch       Date:  2010-03-18       Impact factor: 3.657

2.  The type 1 diabetes - HLA susceptibility interactome--identification of HLA genotype-specific disease genes for type 1 diabetes.

Authors:  Caroline Brorsson; Niclas Tue Hansen; Regine Bergholdt; Søren Brunak; Flemming Pociot
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

3.  Counter regulatory effects of PKCbetaII and PKCdelta on coronary endothelial permeability.

Authors:  Nathalie Gaudreault; Rachel M Perrin; Mingzang Guo; Chase P Clanton; Mack H Wu; Sarah Y Yuan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-22       Impact factor: 8.311

Review 4.  Endothelial cell-cardiomyocyte crosstalk in diabetic cardiomyopathy.

Authors:  Andrea Wan; Brian Rodrigues
Journal:  Cardiovasc Res       Date:  2016-06-10       Impact factor: 10.787

Review 5.  Endothelial response to glucose: dysfunction, metabolism, and transport.

Authors:  Alisa Morss Clyne
Journal:  Biochem Soc Trans       Date:  2021-02-26       Impact factor: 5.407

6.  Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes.

Authors:  April L Darrow; Ralph V Shohet
Journal:  Cardiovasc Diabetol       Date:  2015-06-06       Impact factor: 9.951

7.  Glucose transporter expression in an avian nectarivore: the ruby-throated hummingbird (Archilochus colubris).

Authors:  Kenneth C Welch; Amina Allalou; Prateek Sehgal; Jason Cheng; Aarthi Ashok
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

Review 8.  Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease.

Authors:  Jermaine Goveia; Peter Stapor; Peter Carmeliet
Journal:  EMBO Mol Med       Date:  2014-09       Impact factor: 12.137

9.  CD226 reduces endothelial cell glucose uptake under hyperglycemic conditions with inflammation in type 2 diabetes mellitus.

Authors:  Yuan Zhang; Tian Liu; Yu Chen; Zilong Dong; Jinxue Zhang; Yizheng Sun; Boquan Jin; Feng Gao; Shuzhong Guo; Ran Zhuang
Journal:  Oncotarget       Date:  2016-03-15

10.  Qiliqiangxin attenuates hypoxia-induced injury in primary rat cardiac microvascular endothelial cells via promoting HIF-1α-dependent glycolysis.

Authors:  Yanyan Wang; Xueting Han; Mingqiang Fu; Jingfeng Wang; Yu Song; Yuan Liu; Jingjing Zhang; Jingmin Zhou; Junbo Ge
Journal:  J Cell Mol Med       Date:  2018-03-04       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.